Click to watch the live stream and join the conversation. #PhRMA16

0 SHARES

0

0

0

0

0 SHARES

0

0

0

0

Commitment to Research and Development


Matt Isn't Average


Fighting Rare Diseases


with innovative new medicines

We're Fighting Back


Patients and researchers are working together to fight disease.



The biopharmaceutical industry

continues to be the most R&D-intensive industry in the U.S. economy, and PhRMA member companies are at the forefront. New data show PhRMA member companies invested $58.8 billion in research and development in 2015, up 10.3 percent from 2014.

Learn more



For Cancer Survivors Like Matt, Today is a New Opportunity

Today, with new treatments in the pipeline for cancer, patients and families have more hope than ever before. Learn more about Matt, as he highlights how participation in a clinical trial and innovation from America’s biopharmaceutical research companies has kept him alive.



Medicines in Development for Rare Diseases

More than 560 medicines are in development for rare diseases, including therapies for multiple myeloma, cystic fibrosis and ALS, providing treatment options for patients that had few or no treatment options before.

Learn more



Every Patient Has a Story

At 15 months old, Rhys was unusually tired. His pediatrician quickly figured out why: a tough combination of Type 1 diabetes and Celiac Disease. Fortunately, both can be managed with innovative medicines and diet. Today, Rhys is living the healthy, energetic childhood that every child deserves!

the latest

Get the latest blogs, policy papers, op-eds, and news on patients, innovative medicine development, health care, and more.


  • Fighting for Mental Health

    1 in 25 American adults live with a mental illness. Learn how the biopharmaceutical industry is making progress toward treating mental disorders. #Hope2Cures

    Read more
  • Infographic: The Value of Biopharmaceutical Innovation

    America's biopharmaceutical research companies lead the way in improving patient health, advancing medical innovation and fueling economic growth.

    Read more
  • I'm Not Average: Jamie

    Jamie was diagnosed in 2001 with chronic myelogenous leukemia, and thought she would not be able to watch her son grow up. Today, she is living a happy, normal life. #ImNotAverage

    Read more
  • A voice for patients

    "Being a part of the biopharmaceutical research and development (R&D) process has been incredibly gratifying because our work directly improves people’s lives."

    Read more
  • Targeting the immune system, not the tumor

    Immuno-oncology is based on the concept of harnessing the body’s own immune system to fight cancer.

    Read more
  • Virginia

    In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. #Hope2Cures

    Read more

connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


  • +68K

    Followers

  • +39K

    Followers

  • 366

    Followers

  • 1381

    Subscribers